Biomedical subjects

Aldo Caporossi

Publications and source records attributed to Aldo Caporossi.

22 records · Page 2Linked to original sources

PubMed2002

CD-34 stromal expression pattern in normal and altered human corneas.

OBJECTIVE: To test CD-34 immunoreactivity in stromal cornea cells in normal and pathologic samples obtained from penetrating keratoplasty. DESIGN: Prospective, consecutive histopathologic human tissue study. PARTICIPANTS AND CONTROLS: One hundred two cornea buttons from patients with different diseases, submitted for cornea transplant, were examined. Controls were expired corneas from healthy donor patients who died (n = 4), and globes enucleated for primitive intraocular neoplasias, that is, retinoblastomas (n = 8), and malignant choroidal melanomas (n = 2). METHODS: The expression of CD-34 in stromal cornea cells was examined by immunohistochemistry analysis. Other immunohistochemical stains included an endothelial cell marker (CD-31), common leukocyte antigen, and alpha-smooth muscle actin. MAIN OUTCOME MEASURES: Different diseases that may cause blindness and require penetrating keratoplasty have been tested for CD-34 immunoreactivity. RESULTS: In control corneas, keratocytes present strong and consistent CD-34 immunoreactivity. Diseases leading to the loss of transparency and penetrating keratoplasty, such as keratoconus, herpes keratitis, trauma, and heredofamilial dystrophies, are associated with focal or diffuse loss of CD-34 expression, whereas pseudophakic bullous keratopathy and Fuchs' endothelial dystrophy show normal CD-34 immunoreactivity in most cases and patchy unstained stromal areas in a few cases. CONCLUSIONS: Scar tissue formation in the cornea, as in herpes keratitis and trauma, is always associated with loss of CD-34 immunoreactivity, which may otherwise be a primary event in keratoconus and heredofamilial dystrophies. Both in the pseudophakic bullous keratopathy and Fuchs' endothelial dystrophy, CD-34 immunoreactivity may be normal or lost, hence these two diseases may be considered as one and part of the same group with regard to CD-34 expression, as revealed by immunohistochemistry analysis.

Actins↗

PubMed2002

Preliminary results of cataract extraction with implantation of a single-piece AcrySof intraocular lens.

PURPOSE: To evaluate the intraoperative and postoperative performance of the single-piece AcrySof SA30AL intraocular lens (IOL) in a series of patients after cataract surgery and IOL implantation. SETTING: Department of Ophthalmology and Neurosurgery, University of Siena, Siena, Italy. METHODS: In this prospective study, 20 patients who had phacoemulsification and implantation of a single-piece AcrySof SA30AL lens from March to April 2000 were evaluated. Assessed were control of IOL folding, ease of IOL implantation, IOL centration, intraoperative and postoperative complications, visual acuity, and anterior (ACO) and posterior (PCO) capsule opacification. RESULTS: In all cases, the IOL was easily folded, inserted, and unfolded. It remained well centered in the capsular bag, and there were no intraoperative or postoperative complications. The best corrected visual acuity after surgery was 20/40 or better in all patients. No eye developed ACO or phimosis. One eye had a well-demarcated, oval area of lens epithelial cell proliferation on the posterior capsule that did not impair visual acuity. CONCLUSIONS: Initial results indicate that the single-piece AcrySof SA30AL IOL has good biocompatibility, haptic flexibility and resistance, and stability in the capsular bag. The incidence of PCO in 1 eye could have been the result of several factors and requires further evaluation. An area of future study is the wide haptic of the lens, which may create a path for cells to proliferate as they travel from the equatorial capsule.

Acrylic Resins↗

PubMed2002

Comparison of AcrySof MA30BA and Sensar AR40 acrylic intraocular lenses.

PURPOSE: To compare differences in anterior (ACO) and posterior (PCO) capsule opacification and subjective glare between 2 acrylic intraocular lenses (IOLs): AcrySof MA30BA (Alcon) and Sensar AR40 (Allergan). SETTING: Department of Ophthalmology and Neurosurgery, University of Siena, Siena, Italy. METHODS: This retrospective study comprised 100 cataract patients who had phacoemulsification and IOL implantation. Fifty eyes of 50 patients received an MA30BA and 50 eyes of 50 patients, an AR40. The mean postoperative follow-up was 25 months (range 20 to 31 months) and 22 months (range 19 to 29 months), respectively. Examiners subjectively evaluated ACO, and a photographic image-analysis system was used to assess PCO. All patients received a questionnaire to evaluate the incidence of subjective photic phenomena. RESULTS: In the MA30BA group, 60% had no ACO, 19% had mild ACO, and 21% had anterior capsule fibrosis. In the AR40 group, 55% had no ACO, 27% had mild ACO, and 18% had anterior capsule fibrosis. In the MA30BA group, the mean PCO score measured by image-analysis was 0.043 (range 0.000 to 0.084) at 1 year and 0.125 (range 0.000 to 0.197) at 2 years and in the AR40 group, 0.071 (range 0.000 to 0.157) and 0.230 (range 0.091 to 0.628), respectively. Although the ACO percentages and the PCO scores at 1 year were not statistically different between the 2 groups (P >.05), the MA30BA group had statistically less PCO at 2 years (P <.05). In the MA30BA group, 36 patients had trouble reading in a dim environment, 25 had difficulty driving at night, 25 were mildly bothered by the lights of other vehicles, and 17 saw halos when looking at the lights of other vehicles and 17, when looking at lights at night. In the AR40 group, 7 patients had trouble reading in a dim environment and 11 had difficulty driving at night. At 6 months, the AR40 group had a statistically significantly lower incidence of photic phenomena than the MA30BA group (P <.05). In the MA30BA group 1 year after surgery, 13 patients had trouble reading in a dim environment and 12 had difficulty driving at night. In the AR40 group, 5 patients had trouble reading in a dim environment and 8 had difficulty driving at night. One year after surgery, the difference between the 2 groups in photic phenomena was not statistically significant (P >.05). CONCLUSIONS: The findings indicate that the AcrySof MA30BA has a lower incidence of PCO than the Sensar AR40. The AR40 IOL induced less glare; however, the glare phenomena did not disturb those with an MA30BA lens and the symptoms decreased by 1 year after surgery. These results suggest that both optic design and haptic material influence postoperative clinical results.

Acrylic Resins↗

PubMedDate not supplied

Trypan blue staining of the anterior capsule: the one-drop technique.

Capsule staining is usually a two- or three-stage procedure in which trypan blue is injected under air, a viscoelastic device, viscoelastic mixed with dye, or compartmentalized viscoelastic and balanced salt solution. In these techniques, the consequent irrigation of the anterior chamber with balanced salt solution may lead to a less stable anterior chamber, a decrease of pupil diameter, and damage of the corneal endothelium. A modification of current injection techniques for staining the anterior capsule under a dispersive viscoelastic device with 1 drop of trypan blue by an ordinary 27-gauge anterior chamber cannula is described.

Capsulorhexis↗